ArticleISRN rheumatology2012
Cardiac manifestations of rheumatological conditions: a narrative review.
Article in ISRN rheumatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.
- Heart Involvement in Inflammatory Rheumatic Diseases: A Systematic Literature Review.Medicina (Kaunas, Lithuania) · 2019Pooled it
- Observational
- Aortic Regurgitation in a Patient with Rheumatoid Arthritis/Systemic Lupus Erythematosus Overlap Syndrome (Rhupus): Case Report and Review of Literature.Journal of cardiovascular development and disease · 2025Article
- Impact of systemic autoimmune disorders on in-hospital outcomes of cardiac arrest: a United States national inpatient sample cross-sectional study.Critical care (London, England) · 2025Article
- Autoimmune Pericarditis: Diagnosis and New Therapeutics.Current cardiology reports · 2025Review
- Blood coagulation monitoring of patients with mechanical heart valve visiting Imam.Journal of cardiothoracic surgery · 2025Article
- Blue Toe Syndrome in Behçet's Disease: A Case Report.The American journal of case reports · 2024Article
- Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosis.RMD open · 2024Article
- Shifting perspectives in coronary involvement of polyarteritis nodosa: case of 3-vessel occlusion treated with 4-vessel CABG and review of literature.BMC cardiovascular disorders · 2024Review
- Rheumatoid Arthritis and Pericardial Effusion - A Unique Major Manifestation.European journal of case reports in internal medicine · 2024Article
- Quadricuspid Aortic Valve and Rheumatoid Arthritis: A Coincidence or Interconnection.Clinical medicine insights. Case reports · 2024Article
- Ventricular and atrial function assessment with transthoracic echocardiography in patients with rheumatic inflammatory disease.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2022Article
- Cardiovascular Risk Prediction Parameters for Better Management in Rheumatic Diseases.Healthcare (Basel, Switzerland) · 2022Review
- Article
- Increased risk of valvular heart disease in patients with ankylosing spondylitis: a nationwide population-based longitudinal cohort study.Therapeutic advances in musculoskeletal disease · 2021Article
- Pericarditis in Systemic Rheumatologic Diseases.Current cardiology reports · 2020Review
- Aortic Dissection: An Easily Missed Diagnosis when Pain Doesn't Hold the Stage.The American journal of case reports · 2019Article
- Cardiac tamponade in a patient with ankylosing spondylitis: a notable response to TNF inhibitors.BMJ case reports · 2018Article
- Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions.International journal of clinical rheumatology · 2015Article
- Cardiorheumatology: cardiac involvement in systemic rheumatic disease.Nature reviews. Cardiology · 2015 · on this mapReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases are common in systemic rheumatologic diseases. They can be presented at the time of diagnosis or after diagnosis. The cardiac involvements can be the first presentation of rheumatologic conditions. It means that a patient with rheumatologic disease may go to a cardiologist when attacked by this disease at first. These manifestations are very different and involve different structures of the heart, and they can cause mortality and morbidity of patients with rheumatologic diseases. Cardiac involvements in these patients vary from subclinical to severe manifestations. They may need aggressive immunosuppressive therapy. The diagnosis of these conditions is very important for choosing the best treatment. Premature atherosclerosis and ischemic heart disease are increased in rheumatoid arthritis and systemic lupus erythematosus, and may be causes of mortality among them. The aggressive control of systemic inflammation in these diseases can reduce the risk of cardiovascular disease especially ischemic heart disease. Although aggressive treatment of primary rheumatologic diseases can decrease mortality rate and improve them, at this time, there are no specific guidelines and recommendations, to include aggressive control and prevention of traditional risk factors, for them.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.